THE OSI COLLECTIONS
ABOUT THE OSI
Open access articles:
No. of contributors:
Lung squamous cell carcinoma with solitary ocular metastasis and its successful treatment with thoracic surgery and chemotherapy: an interesting and rare case report
Journal – BMC cancer
Publication date – Oct – 2018
Authors – Guo, Y; Wang, X; Xiao, J; Xu, Y; Cai, Y; Sun, C; Ma, K
Keywords – Lung squamous cell carcinoma; Multidisciplinary treatment; Solitary ocular metastasis
Open access – Yes
Speciality – Cardiothoracic surgery, Ophthalmology
World region Southern Asia
Language – English
Submitted to the One Surgery Index on October 30, 2018 at 8:25 pm
The incidence of ocular metastasis from lung cancer is reported to be 0.1-7%, with adenocarcinoma and small cell lung cancer accounting for the highest proportions of these cases. The majority of cases involves metastasis to more than one other distal organ in addition to the eye. Here, we report for the first time, a case of lung squamous cell carcinoma with solitary symptomatic ocular metastasis as the initial manifestation that was managed by a multidisciplinary treatment (MDT).
A woman presented at the ophthalmology department of hospital with a 1-week history of left eye pain and blurred vision. Systemic examination led to the diagnosis of central lung cancer in the right lower lobe with ocular metastasis. After consultations with an MDT, including specialists from the surgery, internal medicine, ophthalmology, radiotherapy and imaging departments, the patient underwent surgery and chemotherapy. Her eye symptoms disappeared, and the ocular lesion was well controlled without any specific ocular treatment. The patient demonstrated a prolonged progression-free survival.
This is the first report of a rare case with solitary ocular metastasis as the initial manifestation of lung squamous cell carcinoma. This rare patient was treated based on evidence-based medicine, indicating the importance of cooperation within an MDT. The successful treatment of this case was reported as a new therapeutic reference for clinicians who encounter similar cases in the future.
OSI Number – 20264
PMID – 30342504